Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Calgary

$105,000.00

Defining the systems level biology of microbiome-immune interactions in critical illness for the development of targeted therapeutics and interventions.

EF 2022-23

Résumé
Critically ill patients in the ICU experience extreme rates of hospital-acquired infections (up to 50%). This hyper-susceptibility to secondary infections is largely attributed to systemic immune disruption and weakened host defenses against infections, yet the underlying causes mediating this critical illness-associated immune dysfunction are not well known. Furthermore, patients admitted to the ICU display profound intestinal dysbiosis. The significant contributions of the microbiome for early life immune development are well known, but it is also apparent that insult to the microbiome can have profound impacts on systemic immunity. Therefore, we hypothesize that critical illness-associated immune dysfunction is promoted by intestinal dysbiosis and an injured microbiome community, resulting in susceptibility to secondary infections in the ICU. We performed a prospective, longitudinal cohort study of patients admitted to a multi-system ICU in Calgary, AB (N=51). Using serial fecal and blood sampling (days 1, 3, 7, 14), we employed a multi-omics and systems-based analysis of microbiome composition, immune landscape, and clinical outcomes to enable a robust and in-depth analysis of the "immunobiome" of critically ill patients. Our data has shown that roughly 50% of ICU patients have severe intestinal dysbiosis, driven by the enrichment of notable bacteria Enterobacteriaceae and these patients were found to be at greater risk of acquiring a hospital-acquired infection. Coinciding with this enrichment, we observe significant alteration of key innate immune cells which are important in our bodies first line of defense against infections. Next, we aim to describe the causal mechanisms linking intestinal dysbiosis and impaired immune activity in critically ill patients. Utilizing a germ-free mouse model in which we can engraft the microbiome of ICU patients, we aim to further characterize this pathological phenomenon between microbiome and host immunity.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
475958
Name
Schlechte Jared
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Defining the systems level biology of microbiome-immune interactions in critical illness for the development of targeted therapeutics and interventions.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Critical Illness; Germ-Free; Gnotobiotic; Immunology; Infectious Diseases; Microbiome; Microbiome-Immune Interactions; Multi-Omics; Sepsis; Systems Biology
Abstract
Critically ill patients in the ICU experience extreme rates of hospital-acquired infections (up to 50%). This hyper-susceptibility to secondary infections is largely attributed to systemic immune disruption and weakened host defenses against infections, yet the underlying causes mediating this critical illness-associated immune dysfunction are not well known. Furthermore, patients admitted to the ICU display profound intestinal dysbiosis. The significant contributions of the microbiome for early life immune development are well known, but it is also apparent that insult to the microbiome can have profound impacts on systemic immunity. Therefore, we hypothesize that critical illness-associated immune dysfunction is promoted by intestinal dysbiosis and an injured microbiome community, resulting in susceptibility to secondary infections in the ICU. We performed a prospective, longitudinal cohort study of patients admitted to a multi-system ICU in Calgary, AB (N=51). Using serial fecal and blood sampling (days 1, 3, 7, 14), we employed a multi-omics and systems-based analysis of microbiome composition, immune landscape, and clinical outcomes to enable a robust and in-depth analysis of the "immunobiome" of critically ill patients. Our data has shown that roughly 50% of ICU patients have severe intestinal dysbiosis, driven by the enrichment of notable bacteria Enterobacteriaceae and these patients were found to be at greater risk of acquiring a hospital-acquired infection. Coinciding with this enrichment, we observe significant alteration of key innate immune cells which are important in our bodies first line of defense against infections. Next, we aim to describe the causal mechanisms linking intestinal dysbiosis and impaired immune activity in critically ill patients. Utilizing a germ-free mouse model in which we can engraft the microbiome of ICU patients, we aim to further characterize this pathological phenomenon between microbiome and host immunity.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schlechte, Jared
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~